Prospective Evaluation of Testosterone Fluctuations During a Transition from Degarelix to Leuprolide - Jack Zuckerman

February 11, 2015

Prospective Evaluation of Testosterone Fluctuations During a Transition of Therapy from Degarelix to Leuprolide in Patients on Androgen Deprivation Therapy

Jack Zuckerman, MD
Eastern Virginia Medical School
Norfolk, Virginia


Prospective evaluation of testosterone fluctuations during a transition of therapy from degarelix to leuprolide in patients on androgen deprivation therapy - Abstract

The Efficacy and Safety of Degarelix: A 12-Month, Comparative, Randomized, Open-Label, Parallel-Group Phase III Study in Patients with Prostate Cancer - Abstract


Dr. Zuckerman attended medical school at Wake Forest University School of Medicine.  He completed his internship in General Surgery at the Naval Medical Center in San Diego and then went on to finish his Urology residency at Eastern Virginia Medical School in Norfolk, Virginia.  He is currently a fellow in genitourinary reconstruction at Eastern Virginia.  His research interests are primarily male reconstruction, including ongoing prospective randomized controlled trials.  While his focus is urologic reconstruction he has published on a variety of other urologic topics, including oncology and general urology.